John W. Shiver - 10 Mar 2026 Form 4 Insider Report for NOVAVAX INC (NVAX)

Role
Director
Signature
/s/ Mark J. Casey, Attorney-in-Fact
Issuer symbol
NVAX
Transactions as of
10 Mar 2026
Net transactions value
$0
Form type
4
Filing time
12 Mar 2026, 17:00:14 UTC
Previous filing
12 Mar 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Shiver John W. Director C/O NOVAVAX, INC., 21 FIRSTFIELD ROAD, GAITHERSBURG /s/ Mark J. Casey, Attorney-in-Fact 12 Mar 2026 0001900372

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVAX Common Stock Options Exercise +7,947 $0.000000* 7,947 10 Mar 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVAX Restricted Stock Units Options Exercise -7,947 -33% $0.000000* 15,893 10 Mar 2026 Common Stock 7,947 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The RSUs subject to this grant under the Restated 2015 Stock Incentive Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of March 10, 2025, in each case subject to continued service on the Company's Board of Directors through such vesting date